RxDoctor Payments Data

Horacio Asbun, MD

Surgical Oncology · Miami, FLNPI 1285638015

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $96,642 of the $160,853 with a category attached, or 60.1%. 12 manufacturers reported payments, led by Stryker at 50.0% of the total. Reporting peaked in 2024 at $49,996 and has fallen 61.8% since, to $19,091 in 2025. Among surgical oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$160,853in general payments, 2019–2025

Across 104 payments — averaging $1546.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$80K
  • Boston Scientific$53K
  • Olympus America Inc.$20K
  • Olympus Corporation$3K
  • Johnson & Johnson$3K
  • KARL Storz Endoscopy-america$701
  • plus $902 from 6 others

What the payments were for

  • Consulting fees$96,64260%
  • Speaking & faculty fees$16,98011%
  • Travel & lodging$43,89227%
  • Food & beverage$3,3392%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$160,853 in reported general payments places this provider in the 95th percentile of 133 surgical oncology providers in Florida.

See all surgical oncology providers in Florida

Medicare billing

Part B allowed, 2024
$46,176
Medicare patients
66
Services billed
120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →